Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part I: Theory and model validation
暂无分享,去创建一个
[1] Marianne Geiser,et al. Deposition and biokinetics of inhaled nanoparticles , 2010, Particle and Fibre Toxicology.
[2] W. Busse,et al. Evolution of dry powder inhaler design, formulation, and performance. , 2002, Respiratory medicine.
[3] Designing aerosol size distribution to minimize inter-subject variability of alveolar deposition , 2016 .
[4] Werner Hofmann,et al. A computer program for the simulation of fiber deposition in the human respiratory tract , 2006, Comput. Biol. Medicine.
[5] G. Keating,et al. Novolizer: a multidose dry powder inhaler. , 2003, Drugs.
[6] William L. Roberts,et al. A new methodology for targeting drug-aerosols in the human respiratory system , 2008 .
[7] P. Chakravarty,et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. , 2008, American journal of respiratory cell and molecular biology.
[8] K. Kurdziel,et al. Condensational Growth May Contribute to the Enhanced Deposition of Cigarette Smoke Particles in the Upper Respiratory Tract , 2008 .
[9] J. Heyder,et al. Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .
[10] M. Paiva,et al. One-dimensional simulation of aerosol transport and deposition in the human lung. , 1994, Journal of applied physiology.
[11] David M. Broday,et al. Growth and Deposition of Hygroscopic Particulate Matter in the Human Lungs , 2001 .
[12] C. Pope,et al. Ischemic Heart Disease Events Triggered by Short-Term Exposure to Fine Particulate Air Pollution , 2006, Circulation.
[13] H. Yeh,et al. Models of human lung airways and their application to inhaled particle deposition. , 1980, Bulletin of mathematical biology.
[14] J. Fleming,et al. A comparison of planar scintigraphy and SPECT measurement of total lung deposition of inhaled aerosol. , 2003, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[15] J Schwartz,et al. Particulate air pollution and chronic respiratory disease. , 1993, Environmental research.
[16] Runyu Yang,et al. CFD-DEM investigation of the dispersion mechanisms in commercial dry powder inhalers , 2013 .
[17] G. Rudolf,et al. Intercomparison of Experimental Regional Aerosol Deposition Data , 1989 .
[18] R. Hermann,et al. Scintigraphic comparison of budesonide deposition from two dry powder inhalers. , 2000, The European respiratory journal.
[19] J. Fleming,et al. Comparison of SPECT aerosol deposition data with a human respiratory tract model. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[20] R. Suedee,et al. The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers. , 2005, Journal of pharmaceutical sciences.
[21] T. Martonen. Analytical model of hygroscopic particle behavior in human airways. , 1982, Bulletin of mathematical biology.
[22] A. Lamprecht,et al. Devices for Dry Powder Drug Delivery to the Lung , 2015, AAPS PharmSciTech.
[23] Bean T. Chen,et al. Particle Deposition in a Cast of Human Oral Airways , 1999 .
[24] L. A. Engel,et al. The anatomical basis for the sloping N2 plateau. , 1981, Respiration physiology.
[25] Mofid Gorji-Bandpy,et al. Details of regional particle deposition and airflow structures in a realistic model of human tracheobronchial airways: two-phase flow simulation , 2016, Comput. Biol. Medicine.
[26] D. McRobbie,et al. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[27] B. Maury,et al. Multiscale modelling of the respiratory track: a theoretical framework , 2006 .
[28] P. C. Emmett,et al. Measurements of the total and regional deposition of inhaled particles in the human respiratory tract , 1982 .
[29] C. Carrington,et al. Morphometry of the Human Lung , 1965, The Yale Journal of Biology and Medicine.
[30] W. Hofmann,et al. Analysis of human lung morphometric data for stochastic aerosol deposition calculations. , 1985, Physics in medicine and biology.
[31] C. S. Kim,et al. Total respiratory tract deposition of fine micrometer-sized particles in healthy adults: empirical equations for sex and breathing pattern. , 2006, Journal of applied physiology.
[32] J E Hansen,et al. Human air space shapes, sizes, areas, and volumes. , 1975, Journal of applied physiology.
[33] Nazrul Islam,et al. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers. , 2012, Medical engineering & physics.
[34] M. Paiva,et al. Gas transport in a model derived from Hansen-Ampaya anatomical data of the human lung. , 1976, Journal of applied physiology.
[35] Icrp. Human Respiratory Tract Model for Radiological Protection , 1994 .
[36] Yung Sung Cheng,et al. Mechanisms of Pharmaceutical Aerosol Deposition in the Respiratory Tract , 2014, AAPS PharmSciTech.
[37] L. Borgström,et al. Comparison of Gamma Scintigraphy and a Pharmacokinetic Technique for Assessing Pulmonary Deposition of Terbutaline Sulphate Delivered by Pressurized Metered Dose Inhaler , 1995, Pharmaceutical Research.
[38] M. Goldberg,et al. A Systematic Review of the Relation Between Long-term Exposure to Ambient Air Pollution and Chronic Diseases , 2008, Reviews on environmental health.
[39] Computation of the boundary conditions for diffusion in the human lung. , 1972, Computers and biomedical research, an international journal.
[40] Yung-sung Cheng,et al. Particle Deposition in a Cast of Human Tracheobronchial Airways , 2005 .
[41] Joy Conway,et al. Controlled, parametric, individualized, 2D and 3D imaging measurements of aerosol deposition in the respiratory tract of healthy human volunteers: in vivo data analysis. , 2014, Journal of aerosol medicine and pulmonary drug delivery.
[42] W. Finlay,et al. Predicting extrathoracic deposition from dry powder inhalers , 2004 .
[43] Renishkumar R Delvadia,et al. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition. , 2013, Journal of aerosol medicine and pulmonary drug delivery.
[44] Mårten Svensson,et al. Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products. , 2013, Journal of aerosol medicine and pulmonary drug delivery.
[45] T T Soong,et al. Statistical analysis of aerosol deposition in nose and mouth. , 1981, American Industrial Hygiene Association journal.
[46] Arun V. Kolanjiyil,et al. Nanoparticle mass transfer from lung airways to systemic regions--Part II: Multi-compartmental modeling. , 2013, Journal of biomechanical engineering.
[47] P. Barnes. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. , 2013, The Journal of allergy and clinical immunology.
[48] Clement Kleinstreuer,et al. Airflow and Particle Transport in the Human Respiratory System , 2010 .
[49] B. Asgharian,et al. A multiple-path model of fiber deposition in the rat lung. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[50] W. Hofmann,et al. Monte Carlo modeling of aerosol deposition in human lungs. Part I: Simulation of particle transport in a stochastic lung structure , 1990 .
[51] D. Rogers,et al. Curcumin mediated epigenetic modulation inhibits TREM-1 expression in response to lipopolysaccharide. , 2012, The international journal of biochemistry & cell biology.
[52] A. Wexler,et al. The role of dispersion in particle deposition in human airways. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[53] A. Rostami,et al. Evaporation and condensation of multicomponent electronic cigarette droplets and conventional cigarette smoke particles in an idealized G3–G6 triple bifurcating unit , 2015 .
[54] Geoffrey McLennan,et al. Multiscale Simulation of Gas Flow in Subject-Specific Models of the Human Lung , 2009 .
[55] Caroline Majoral,et al. Controlled, parametric, individualized, 2-D and 3-D imaging measurements of aerosol deposition in the respiratory tract of healthy human subjects for model validation , 2012 .
[56] Hak-Kim Chan,et al. In vitro/in vivo comparisons in pulmonary drug delivery. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[57] L. Helson. Curcumin (diferuloylmethane) delivery methods: A review , 2013, BioFactors.
[58] N. Chaiyaratana,et al. Variable-length haplotype construction for geneߝgene interaction studies , 2009, IEEE Engineering in Medicine and Biology Magazine.
[59] Morton Lippmann,et al. Regional Deposition of Particles in the Human Respiratory Tract , 2011 .
[60] C. Kleinstreuer,et al. Airflow structures and nano-particle deposition in a human upper airway model , 2004 .
[61] Miroslav Jicha,et al. A method for in vitro regional aerosol deposition measurement in a model of the human tracheobronchial tree by the positron emission tomography , 2015, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.
[62] Warren H. Finlay,et al. The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction , 2001 .
[63] David F. Fletcher,et al. Influence of Mouthpiece Geometry on the Aerosol Delivery Performance of a Dry Powder Inhaler , 2007, Pharmaceutical Research.
[64] D E Olson,et al. Models of the human bronchial tree. , 1971, Journal of applied physiology.
[65] W. Finlay,et al. Experimental measurements of particle deposition in three proximal lung bifurcation models with an idealized mouth-throat. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[66] Jianjun Liu,et al. SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells , 2010, Particle and Fibre Toxicology.
[67] Lianzhong Zhang,et al. Moving boundary simulation of airflow and micro-particle deposition in the human extra-thoracic airway under steady inspiration. Part I: Airflow , 2013 .
[68] M Ismail,et al. Coupled and reduced dimensional modeling of respiratory mechanics during spontaneous breathing , 2013, International journal for numerical methods in biomedical engineering.
[69] I. Rahman,et al. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. , 2005, Antioxidants & redox signaling.
[70] Gabriela Apiou-Sbirlea,et al. The use of combined single photon emission computed tomography and X-ray computed tomography to assess the fate of inhaled aerosol. , 2011, Journal of aerosol medicine and pulmonary drug delivery.
[71] J. Fleming,et al. Controlled, Parametric, Individualized, 2D, and 3D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Healthy Human Subjects: Preliminary Comparisons with Simulations , 2013 .
[72] Jung-Il Choi,et al. Mathematical Analysis of Particle Deposition in Human Lungs: An Improved Single Path Transport Model , 2007, Inhalation toxicology.
[73] J. Gore,et al. Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[74] P. Worth Longest,et al. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data , 2015, Pharmaceutical Research.
[75] C Kleinstreuer,et al. An adjustable triple-bifurcation unit model for air-particle flow simulations in human tracheobronchial airways. , 2009, Journal of biomechanical engineering.
[76] Yu Feng,et al. Drug-targeting methodologies with applications: A review. , 2014, World journal of clinical cases.
[77] Ahmed Fadl,et al. Effects of MDI spray angle on aerosol penetration efficiency through an oral airway cast , 2007 .
[78] Clement Kleinstreuer,et al. Comparison of micro- and nano-size particle depositions in a human upper airway model , 2005 .
[79] S. Newman,et al. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients. , 2001, Respiratory medicine.
[80] M Paiva,et al. Pulmonary interdependence of gas transport. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.
[81] A. Black,et al. Regional deposition of 2.5-7.5 μm diameter inhaled particles in healthy male non-smokers , 1978 .
[82] O. Usmani,et al. Regional Lung Deposition and Bronchodilator Response as a Function of β2-Agonist Particle Size , 2005 .
[83] Clement Kleinstreuer,et al. Cyclic micron-size particle inhalation and deposition in a triple bifurcation lung airway model , 2002 .
[84] C. Kleinstreuer,et al. Laminar‐to‐turbulent fluid–nanoparticle dynamics simulations: Model comparisons and nanoparticle‐deposition applications , 2011 .
[85] Anthony S. Wexler,et al. Modeling aerosol bolus dispersion in human airways , 1999 .
[86] Kenneth R. Lutchen,et al. An Anatomically Based Hybrid Computational Model of the Human Lung and its Application to Low Frequency Oscillatory Mechanics , 2006, Annals of Biomedical Engineering.
[87] W. Finlay,et al. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[88] D. Taulbee,et al. A theory of aerosol deposition in the human respiratory tract. , 1975, Journal of applied physiology.
[89] M. Dolovich,et al. Aerosol drug delivery: developments in device design and clinical use , 2011, The Lancet.
[90] H. Chan,et al. Pulmonary drug delivery by powder aerosols. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[91] Eric A Hoffman,et al. Regional Deposition of Particles in an Image-Based Airway Model: Large-Eddy Simulation and Left-Right Lung Ventilation Asymmetry , 2011, Aerosol science and technology : the journal of the American Association for Aerosol Research.
[92] P. Barry,et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. , 2001, Health technology assessment.
[93] Otto G. Raabe,et al. Tracheobronchial Geometry: Human, Dog, Rat, Hamster - A Compilation of Selected Data from the Project Respiratory Tract Deposition Models , 1976 .
[94] Andrew R. Martin,et al. Recent advances in predictive understanding of respiratory tract deposition. , 2008, Journal of aerosol medicine and pulmonary drug delivery.
[95] E. Hoffman,et al. Computational fluid dynamics , 2009, IEEE Engineering in Medicine and Biology Magazine.
[96] R. Suedee,et al. The correlation of urinary levels of albuterol and its metabolites isomers following inhalation from a dry powder inhaler and in vitro particle size characterisation. , 2007, Pulmonary pharmacology & therapeutics.
[97] Clement Kleinstreuer,et al. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology. , 2007, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[98] W. MacNee,et al. Particulate air pollution and acute health effects , 1995, The Lancet.
[99] A. Taylor,et al. The lung deposition of salbutamol, directly labelled with technetium-99m, delivered by pressurised metered dose and dry powder inhalers , 1993 .
[100] W. Hofmann,et al. Modelling inhaled particle deposition in the human lung—A review , 2011 .
[101] P. Worth Longest,et al. Comparing MDI and DPI Aerosol Deposition Using In Vitro Experiments and a New Stochastic Individual Path (SIP) Model of the Conducting Airways , 2012, Pharmaceutical Research.
[102] M. Hindle,et al. Targeted Lung Delivery of Nasally Administered Aerosols , 2014, Aerosol science and technology : the journal of the American Association for Aerosol Research.
[103] M Lippmann,et al. Experimental measurements and empirical modelling of the regional deposition of inhaled particles in humans. , 1980, American Industrial Hygiene Association journal.
[104] C. Kleinstreuer,et al. Computational analysis of airflow and nanoparticle deposition in a combined nasal–oral–tracheobronchial airway model , 2011 .
[105] Clement Kleinstreuer,et al. Analysis of non-spherical particle transport in complex internal shear flows , 2013 .
[106] C. P. Yu,et al. A comparative study of aerosol deposition in different lung models. , 1982, American Industrial Hygiene Association journal.
[107] P. Longest,et al. Inertial deposition of aerosols in bifurcating models during steady expiratory flow , 2009 .
[108] Clement Kleinstreuer,et al. Airflow and Nanoparticle Deposition in a 16-Generation Tracheobronchial Airway Model , 2008, Annals of Biomedical Engineering.
[109] B. Asgharian,et al. A Model of Deposition of Hygroscopic Particles in the Human Lung , 2004 .
[110] W. Finlay,et al. In vitro intersubject and intrasubject deposition measurements in realistic mouth-throat geometries , 2004 .
[111] C. P. Yu. Exact analysis of aerosol deposition during steady breathing , 1978 .
[112] P Worth Longest,et al. In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans. , 2012, Journal of aerosol medicine and pulmonary drug delivery.
[113] D. Cui,et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles , 2012, International journal of nanomedicine.
[114] C. Kleinstreuer,et al. A Lagrangian Approach for Calculating Microsphere Deposition in a One-Dimensional Lung-Airway Model. , 2015, Journal of biomechanical engineering.
[115] W. Hofmann,et al. Particle Deposition in a Multiple-Path Model of the Human Lung , 2001 .
[116] Clement Kleinstreuer,et al. Nanoparticle mass transfer from lung airways to systemic regions--Part I: Whole-lung aerosol dynamics. , 2013, Journal of biomechanical engineering.